International Validation of Two Non-motor Scales in PD (NFS and SPARK)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-75
SponsorInsel Gruppe AG, University Hospital Bern
About this trial
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).
Eligibility criteria
Qualifiers
Written informed consent;
PD, according to the MDS criteria;
Age of participants > 30 and < 75 years;
Being fluent in the language in which the scales are applied.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsSponsors and collaborators
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Michael J. Fox Foundation for Parkinson's Research
Collaborator
Carlos III Health Institute
Collaborator
Source ClinicalTrials.gov